Next-gen Stitches

A revolutionary tissue repair gel developed at Auckland University has secured NZ$15 million in US funding, thanks to the efforts of key developer Professor Colin Green. The US financial backing will help commercialise the drug – Nexagon – which is aimed at an international market worth billions. If trials are successful, Nexagon will initially be used for treating eye and skin wounds. The drug could then be further developed for use on burns, skin grafts and possibly even surgery on joints.